Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antihemophilic Factor, Human Recombinant

Known as: Factor VIII, Antihemophilic factor human, Factor VIII (Recombinant) 
The recombinant form of human antihemophilic factor (AH)) (Factor VIII) with coagulation promoting activity. Antihemophilic factor binds to factor… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Summary.  Background: Hemophilia A results from a deficiency in factor VIII activity. Current treatment regimens require frequent… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Summary.  Background: Prophylaxis with factor (F)VIII is considered the optimal treatment for managing hemophilia A patients… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
A longer acting recombinant FVIII is expected to serve patients' demand for a more convenient prophylactic therapy. We have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Co-axial electrospun fibers can offer both topographical and biochemical cues for tissue engineering applications. In this study… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Summary.  Background: The pharmacokinetics of factor VIII replacement therapy in preschool previously treated patients (PTPs… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Effective oral delivery of a non-viral gene carrier would represent a novel and attractive strategy for therapeutic gene transfer… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Summary.  The efficacy and safety of an advanced category recombinant antihaemophilic factor produced by a plasma‐ and albumin… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Summary.  Patients with hemophilia have an impaired thrombin generation and therefore form loose fibrin hemostatic plugs that are… Expand
Is this relevant?
Review
2003
Review
2003
Besides preventing bleeding episodes, common goals of the treatment of hemophilia include integrating of patients into a normal… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The protein cofactor, factor (F) VIIIa, is required for the efficient conversion of the substrate FX to FXa by the serine… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 5
Is this relevant?